Chu S. Freedom from Cigarettes: Strategies to Help Quit Smoking. Poster presented during 371 outpatient practicum. 2021 Aug 27; Campbell River, BC

Chu S, Yu S, Carlaw T, Zhang, L. An eGFP Model for In Vitro Genome Editing. Poster presented at Summer Student Research Program. 2019 Sep 20; Vancouver, BC

Chu S. Enhancing CRISPR/Cas9 Gene Efficiency in the Correction of Mutations Causing Sanfilippo B Syndrome. Poster presented at Jamie Cassels Undergraduate Research Award conference. 2018 Mar 4; Victoria, BC

Chu S, Christensen C, Choy FYM. The impact of GC content on CRISPR/Cas9 gene editing: Implications for mucopolysaccharidosis III B. Presented at the We're Organizing Research on Lysosomal Diseases (WORLD) Symposim. 2018 Feb 5-8; San Diego, California

Christensen C, Wells-Durand E, Hilton AM, Thompson J, Chu S, and Choy FYM. (2021). Base editing of GBA1 and HPRT1 reveals a target nucleotide preference centered within the editing window. Manuscript submitted for publication.

Christensen C, Wells-Durand E, Hilton AM, Thompson J, Chu S, and Choy FYM. (2020). Base editing of the N370S mutation in Gaucher disease skin fibroblasts. Molecular Genetics and Metabolism. 132. S26. Doi.org/10.1016/j.ymgme.2020.12.042.

Christensen C, Ashmead R, Chu S, and Choy FYM. (2019). Delivery of adenine base editors to patient-derived induced pluripotent stem cells in vitro: A putative treatment for mucopolysaccharidosis type IIIB. Molecular Genetics and Metabolism. 126. S39. Doi.org/10.1016/j.ymgme.2018.12.081.

Chu S. (2018). Reprogramming Sanfilippo B fibroblasts to Induced Pluripotent Stem Cells and CRISPR/Cas9 gene editing of Sanfilippo B mutations [Undergraduate Honours Thesis]. University of Victoria, Victoria, BC.

Chu S, Christensen C, and Choy FYM. (2018). The impact of GC content on CRISPR/Cas9 gene editing: implications for mucopolysaccharidosis type IIIB. Molecular Genetics and Metabolism. 123. S32. Doi.org/10.1016/j.ymgme.2017.12.061.